Concepedia

Yuebi Hu

YH

7

Publications

1.5K

Citations

7

H-Index

2017

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Levine Cancer Institute

Tufts University

Brigham and Women's Hospital

Harvard University

Yuebi Hu is an author at Dana-Farber Cancer Institute specializing in drug resistance, medicine, and genetics.

Top concepts

Publications per year

2017–2019

7

Publications

7

Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

Geoffrey R. Oxnard, Yuebi Hu, Kathryn F. Mileham et al. · JAMA Oncology · 2018 · 673 citations · Full text

False-Positive Plasma Genotyping Due to Clonal Hematopoiesis

Yuebi Hu, Bryan C. Ulrich, Julianna Supplee et al. · Clinical Cancer Research · 2018 · 423 citations

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium

B.T. Li, Filip Jankú, B. Jung et al. · Annals of Oncology · 2019 · 154 citations · Full text

Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer

Nicolas Guibert, Yuebi Hu, Nora Feeney et al. · Annals of Oncology · 2018 · 133 citations · Full text

Discrimination of Germline <i>EGFR</i> T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients

Yuebi Hu, Ryan S. Alden, Justin I. Odegaard et al. · Clinical Cancer Research · 2017 · 84 citations · Full text

Rows per page

1–5 of 7